[Observations of the course of scleroderma after combined Hylase-carnitine therapy].
D002331:Carnitine / Q000627:therapeutic use*; D004341:Drug Evaluation; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000627:therapeutic use*; D012594:Scleroderma, Localized / Q000188:drug therapy*; D012595:Scleroderma, Systemic / Q000188:drug therapy*
D006821:Hyaluronoglucosaminidase; D002331:Carnitine
Verlaufsbeobachtungen der Sklerodermie nach kombinierter Hylase-Carnitin-Therapie